Your browser doesn't support javascript.
loading
Letter: hepatocellular carcinoma risk in patients with non-selective beta blockers-authors' reply.
Wijarnpreecha, Karn; Li, Fang; Dang, Yifang; Taner, C Burcin; Yang, Liu; Tao, Cui.
Affiliation
  • Wijarnpreecha K; Department of Transplantation, Mayo Clinic, Jacksonville, Florida, USA.
  • Li F; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.
  • Dang Y; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Taner CB; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Yang L; Department of Transplantation, Mayo Clinic, Jacksonville, Florida, USA.
  • Tao C; Department of Transplantation, Mayo Clinic, Jacksonville, Florida, USA.
Aliment Pharmacol Ther ; 54(8): 1095-1096, 2021 10.
Article in En | MEDLINE | ID: mdl-34564885

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Country of publication: